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Background: In infants, vitamin B12 deficiency may be due to an inborn error of absorption and metabolism, or
nutritional problems.
Case presentation: An exclusively breastfed 5-month-old Italian male infant, who was born after a normal full-term
pregnancy to a vegan mother who was apparently daily treated with a multivitamin oral preparation during the
second and third trimester, was hospitalised because of poor weight gain, feeding difficulties, severe pallor, muscle
hypotonia and somnolence. Upon admission, his weight, length and head circumference were below the third
percentile, he had an enlarged liver and spleen, and showed a significant delay in developmental milestones and
communicative reactions. He had a hemoglobin level of 4.7 g/dL with an MCV of 84.2 fL, a white blood cell count
of 4,680/mm3, and a platelet count of 45,000/mm3. His serum vitamin B12 level was 57 pg/mL (normal value
180–500 pg/mL) and serum folate level 12.8 ng/mL (normal value >3 ng/mL). The results of metabolic
examinations excluded a cobalamin C disorder, whereas nutritional screening showed a serum iron concentration
of 9 μg/dL and serum ferritin of 4 ng/mL. Magnetic resonance imaging of the brain showed mild dilatation of the
lateral ventricles with diffuse delayed myelination. The child was diagnosed as having vitamin B12 and iron
deficiency due to nutritional inadequacy and was immediately treated with packed red blood cells, intramuscular
vitamin B12 injections, and iron supplementation. A few days after the start of therapy, his hemoglobin levels and
other hematological parameters rapidly improved, and a clinical improvement was observed within few weeks.
There was an increase in his achievement of developmental milestones, but his development was still retarded
seven months after the start of therapy.
Conclusion: This case underlines the importance of adequately controlling maternal vitamin B12 intake during
pregnancy by means of supplementation which, in the case of vegan mothers, should be significantly greater than
that usually given. Moreover, the supplementation should be continued during lactation in order to avoid the
development of signs of deficiency that may be associated with persistent neurological problems in infants. The
case also highlights the need to consider vitamin B12 deficiency in infants with severe anemia even if their
hematological parameters do not indicate megaloblastic anemia because the concomitant presence of substantial
iron deficiency may modify the characteristics of the anemia.
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Vitamin B12 plays a major role in human intermediary
metabolism. It is required to convert methylmalonyl-
CoA to succinyl-CoA (a compound metabolised by the
Krebs cycle to produce energy) and to ensure the activity
of methionine synthase, an enzyme that catalyses the
methylation of homocysteine to form the essential
amino acid methionine [1].
Vitamin B12 deficiency leads to the accumulation of
methylmalonic acid and homocysteine in blood and
urine, and the onset of clinical hematological, neuro-
logical and psychiatric manifestations [2]. Vitamin B12
deficiency in infancy may be due to an inborn error of
absorption and metabolism, or (more frequently) nutri-
tional problems. The most frequent inborn error is co-
balamin C disorder, which is caused by a mutation of
the MMACHC gene encoding a protein that plays a crit-
ical role in the metabolic pathway leading to the forma-
tion of succinyl-CoA and methionine [3]. However, most
infants with B12 deficiency are born to women with low
vitamin B12 levels and have been exclusively breastfed.
Vitamin B12 is only found in animal products such as
meat, egg, fish and milk [4]. Consequently, the breast
milk of mothers who do not consume such products is
frequently poor in vitamin B12, and their newborn
infants have low vitamin stores.
We describe the case of an exclusively breastfed 5-
month-old Italian infant with severe pancytopenia and
neurological impairment who was born to a vegan
mother who had received B12 supplementation during
pregnancy but not during lactation.
Case presentation
This five-month-old male Italian infant was born after a
normal full-term (41 weeks) pregnancy with a weight of
2,550 g (3rd percentile), length of 48 cm (10th percentile)
and head circumference of 35 cm (25th percentile). His
mother, who had been vegan for several years, was ap-
parently daily treated with a multivitamin oral prepar-
ation with a multivitamin preparation (Multicentrum,
Pfizer Consumer Healthcare, Rome, Italy) during the
second and third trimester in order to ensure an intake
of 2.5 μg of vitamin B12 per day. Unfortunately, this
supplementation was stopped after delivery. The child
was exclusively breastfed until the fifth month of life,
when he was hospitalised because of poor weight gain,
feeding difficulties, severe pallor, muscle hypotonia and
somnolence. The parents reported that some of these
signs had been present from the third month of life. The
child was seen by a paediatrician at the age of one
month and three months, and physical evaluation
resulted normal. Physical examination upon admission
confirmed the pallor and revealed that the child was
below the 3rd percentile for weight (4,800 g), length(60 cm) and head circumference (39 cm), had an
enlarged liver and spleen, showed a significant delay in
the developmental milestones and communicative reac-
tions for his age. He had a hemoglobin level of 4.7 g/dL
with an MCV of 84.2 fL, a white blood cell count of
4,680/mm3 and neutrophil count of 1,900 mm3. His
platelet count was 45,000/mm3. The peripheral blood
film showed oval macrocytes, anisopoikilocytosis, hypo-
chromia, anisochromia and hyper-segmented poly-
morphonuclear leukocytes. His serum vitamin B12 level
was 57 pg/mL (normal value 180–500 pg/mL) and
serum folate level 12.8 ng/mL (normal value >3 ng/mL).
Blood homocysteine was 11 μmol/L (normal value 4–
15 μmol/L) and urinary methylmalonic acid 281 mmol/
moL creatinine (normal value <5 mmol/moL creatin-
ine). No intrinsic factor antibodies were found. Hormo-
nal and nutritional screening revealed no other
deficiency except for a serum iron concentration of 9
μcg/dL (normal value >29 μg/dL) and serum ferritin of
4 ng/mL (normal value 20–270 ng/mL). Thalassemia
screening resulted negative. A bone marrow examination
showed a reduced number of red line cells with some
megaloblasts, a small number of dysplastic megakaryo-
cytes, and dysplastic granulopoiesis with asynchronous
maturation processes. Genetic analyses did not find any
MMACHC gene mutations.
Magnetic resonance imaging (MRI) of the brain showed
mild dilatation of the lateral ventricles with diffuse delayed
myelination that was most marked in the brainstem.
Maternal investigations showed a hemoglobin level of
9.1 g/dL with an MCV of 96.4 fL, and serum vitamin
B12 level of 155 pg/mL (no data on maternal serum vita-
min B12 during pregnancy was available).
On the basis of these data, the child was diagnosed as
having vitamin B12 and iron deficiency due to nutri-
tional inadequacy. He was immediately treated with
packed red blood cells, intramuscular vitamin B12 injec-
tions (at a dose of 1,000 μg/day for two weeks followed
by weekly injections at the same dose for six months)
and oral iron supplementation (iron sulphate 3 mg/kg/
day for 3 months).
Table 1 shows the patient’s clinical and laboratory data
upon admission and during follow-up. A few days after
the start of therapy, his hemoglobin levels and other
hematological parameters rapidly improved, and a clin-
ical improvement was observed after a few weeks. The
patient was discharged after 19 days.
In the sixth month of life, the child was weaned and
green vegetables as well as fish was introduced in his
diet. There was an increase in his achievement of devel-
opmental milestones, but he still showed significantly
delayed neuropsychiatric development (mainly in gross
motor function and language) and brain myelination
seven months after the start of therapy.
Table 1 Admission and follow-up clinical and laboratory data of an infant with vitamin B12 deficiency
Parameter Admission Two weeks
after
admission
Three months
after
admission
Five months
after
admission
Seven
months
after
admission
Clinical data
Age, months 5 6 8 10 12
Weight, g 4,800 5,660 6,515 7,000 7,445
Length, cm 60 61.5 65.5 67.5 69
Head
circumference,
cm
39 42 43.5 45 46
Pathological
clinical findings
Poor weight gain, feeding
difficulties, severe pallor,
muscle hypotonia,
somnolence, enlarged liver
and spleen
Persistence of
hypotonia and mildly
enlarged liver and
spleen
Persistence of mild
hypotonia and mildly
enlarged liver and
spleen
Persistence of mild
hypotonia
Persistence of mild hypotonia
Pathological
neurological
findings
Significant delay in
developmental milestones
and communicative reactions
Significant delay in
developmental
milestones and
communicative
reactions
Significant delay in
developmental
milestones and
communicative
reactions
Able to remain seated
with
delay in other
developmental
milestones and
communicative
reactions
Able to remain seated,
delay in gross motor function
and language; Griffith’s scale 86
(normal values, 92–100)
Laboratory
data
Hb, g/dL 4.7 10 n.a. n.a. 12.2
MCV, fL 84.2 91.3 n.a. n.a. 81.2
White blood
cell count,
cells/mm3
4,680 9,810 n.a. n.a. 13,410
Platelet count,
cells/mm3
45,000 492,000 n.a. n.a. 375,000
Peripheral
blood
film
Oval macrocytes,
anisopoikilocytosis,
hypochromia,
anisochromia,
and hypersegmented
polymorphonuclear
leukocytes
Normal n.a. n.a. Normal
Bone marrow
examination
Reduced number of red line
cells with some megaloblasts;
a small number of dysplastic
megakaryocytes; dysplastic
granulopoiesis with
asynchronous maturation
processes
n.a. n.a. n.a. n.a.
Serum vitamin
B12, pg/mL
57 >2,000 n.a. n.a. 1,344
Serum
folic acid,
ng/mL
12.8 14 n.a. n.a. 17.3
Serum iron,
μg/dL
9 76 n.a. n.a. 73
Serum ferritin,
ng/mL
4 ng/mL 31 n.a. n.a. 49
Blood
homocysteine,
μmol/L
11 5.4 n.a. n.a. 2
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Table 1 Admission and follow-up clinical and laboratory data of an infant with vitamin B12 deficiency (Continued)
Urinary
methylmalonic
acid,
μmol/mol
creatinine
281 6 n.a. n.a. 4
MMACHC gene
mutations
None n.a. n.a. n.a. n.a.
Neuroimaging
MRI Mild dilatation of lateral
ventricles with diffuse retarded
myelination, most markedly in
the brainstem
n.a. n.a. n.a. Persistent mild dilatation of lateral
ventricles with diffuse retarded
myelination, most markedly in
the brainstem
MRI: magnetic resonance imaging; n.a.: not available.
Guez et al. BMC Pediatrics 2012, 12:85 Page 4 of 5
http://www.biomedcentral.com/1471-2431/12/85Conclusions
This case of a 5-month-old Italian infant with severe
pancytopenia and neurological impairment born to a
vegan mother who had received B12 supplementation
during pregnancy but not during lactation seems to be
particularly interesting for various reasons.
The first is the fact that it is very important to be aware
that vitamin B12 and iron deficiency can frequently occur
in infants born to vegan mothers (who are increasing in
number in these last years) and these deficits are a pre-
ventable cause of neurodevelopmental delay. The second
is the fact that the mother was treated with a multivitamin
preparation that provided 2.5 μg/day of vitamin B12, an
amount that is quite similar to the 2.6 μg/day recom-
mended for pregnant women by health authorities [5].
Despite this, the infant showed clinical signs clearly attrib-
utable to vitamin B12 deficiency (such as a failure to thrive
and pallor) in the first months of life, which suggests that
the recommended amount of vitamin B12 is not enough
to avoid the early development of disease in the infants of
strictly vegetarian women. Moreover, the concomitant
presence of substantial iron deficiency modified the char-
acteristics of the anemia and may also justify several symp-
toms (i.e., lethargy and irritability) and signs (i.e.,
demyelination and poor developmental progression). In-
stead of significant megaloblastosis, we found red blood
cells with a normal MCV, a finding that initially made it
more difficult to reach a correct diagnosis. This also
underlines the need to determine vitamin B12 and iron
levels in all cases of otherwise unexplained severe anemia
occurring in the first months of life. Finally, the MRI data
confirmed the view of Lovblad et al. [6] that the most im-
portant neurological damage due to vitamin B12 deficiency
is reduced myelination, which can persist for several
months even after the start of supplementation therapy.
The possible development of severe clinical signs of
vitamin B12 deficiency in infants born to undernourished
mothers has been repeatedly described. A recent review
of 134 cases of childhood vitamin B12 deficiency pub-
lished over the last 20 years found that 69 were due tomaternal B12 deficiency, and that more than 50% of these
were directly related to an inadequate consumption of
meat and other animal products such as that usually
characterising strict vegetarians [7]. The children of
women with low vitamin B12 levels during pregnancy
and lactation may have smaller stores of the vitamin at
birth [8], and its concentration in breast milk is likely to
be low [9]. Such children tend to develop signs of vitamin
B12 deficiency generally not before the fourth month of
life, although neonatal cases have also been reported [10].
Childhood vitamin B12 deficiency is probably signifi-
cantly more frequent than usually thought. Various stud-
ies carried out in the developing world or in countries
where vegetarian diets are common have shown that a
large number of mothers and children have low serum
vitamin B12 levels that closely correlate with albeit mild
clinical problems mainly involving the central nervous
system. It has been reported that approximately one-
third of low-income women and children in Guatemala
have deficient (<148 pmol/L) or marginal (148–220
pmol/L) plasma vitamin B12 concentrations, and that
the lowest levels are strictly related to poor growth and
development [11]. In India, where people tend to be
vegetarians, vitamin B12 deficiency during pregnancy is
common [12], and the infants of deficient mothers are
affected by a syndrome including mild developmental re-
gression and alterations in skin pigmentation [13].
Vitamin B12 supplementation in pregnant and lactat-
ing women, and the greater use of complementary vita-
min B12-rich foods in infants aged >6 months are
frequently suggested strategies for reducing the risk of
major clinical signs of deficiency [14,15]. However, it is
difficult to implement preventive programs in the devel-
oping world as economic problems may profoundly im-
pact the consumption of meat and other animal
products. In industrialised countries, where the problem
is less frequent and only vegans are at risk, a correct
evaluation of the mother’s nutritional history and sys-
tematic supplementation during pregnancy and lactation
can easily prevent the problem. Unfortunately, there is a
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of micronutrient supplements for pregnant women, and
the need to continue their administration after delivery
is not recognised in many situations in which maternal
and infant health might benefit [16].
Despite a low vitamin B12 intake and significant defi-
ciency, pregnant women generally show no related signs
or symptoms because they usually consume large
amounts of vegetables containing high folate concentra-
tions that may mask the hematological effects of vitamin
B12 deficiency. Furthermore, the neuropsychiatric symp-
toms of vitamin B12 deficiency are usually mild in ado-
lescents and adults, and may therefore be overlooked.
On the contrary, young infants frequently have mul-
tiple deficiencies and so, particularly when they are ex-
clusively breastfed, they develop hematological disease
with anemia and (in the most severe cases) pancyto-
penia. As the developing central nervous system seems
to be more sensitive to vitamin B12 deficiency than that
of adults [17], breastfed infants born to vegan mothers
may experience substantial neurological damage with
developmental delay, irritability, tremor and convulsions.
Furthermore, these may persist and lead to long-term
cognitive and developmental delay despite adequate
therapy and the complete disapperance of hematological
problems [18].
As in our case, treated vitamin B12 and iron deficient
infants tend to improve rapidly: hematological values
quickly return to normal, and the neurological signs pro-
gressively decrease. However, in most of the severe cases
described thus far [18], some neurological problems may
be permanent.
In conclusion, this case underlines the importance of
adequate maternal vitamin B12 intake during pregnancy
by means of supplementation which, in the case of
vegans, should be significantly greater than that usually
given. Moreover, the supplementation should be contin-
ued during lactation in order to avoid the development
of signs of deficiency that may be associated with per-
sistent neurological problems in infancy. This case also
highlights the need to consider vitamin B12 deficiency
in infants with severe anemia even if their hematological
parameters do not indicate megaloblastic anemia be-
cause the concomitant presence of substantial iron defi-
ciency may modify the characteristics of the anemia.
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